Skip to content
TrackPodcasts
newsDec 2, 20196:24pending

Monitor

Monitor

About this episode

Een van die faktore wat deur farmaseutiese maatskappye oorweeg word wanneer nuwe middels bekendgestel word, is gesondheidsfassiliteite se vermoë om die behandeling suksesvol toe te pas en voort te sit. In ons laaste bydrae oor die verhouding tussen die beskerming van intellektuele eiendom, teenoor toegang tot lewensnoodsaaklike medikasie, het Marlinee Fouche gaan ondersoek instel na die onderstrominge tussen farmaseutiese maatskappye, hulle generiese vennote en regerings...

Get every episode summarized

Each time Monitor publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Monitor

Monitor

0:00
6:24

More episodes

More from Monitor

View all episodes →